A new echocardiographic parameter of arterial stiffness in end-stage renal disease

被引:1
|
作者
Sahin, M. [1 ]
Simsek, H. [1 ]
Akyol, A. [2 ]
Akdag, S. [1 ]
Yaman, M. [1 ]
Aydin, C. [3 ]
Kul, S. [4 ]
Soyoral, Y. [5 ]
Gumrukcuoglu, H. A. [1 ]
机构
[1] Yuzuncu Yil Univ, Dept Cardiol, Fac Med, Van, Turkey
[2] Van High Educ & Reseach Hosp, Dept Cardiol, Van, Turkey
[3] Bezmialem Fdn Univ, Cardiovasc Surg Dept, Istanbul, Turkey
[4] Bezmialem Fdn Univ, Dept Cardiol, Istanbul, Turkey
[5] Yuzuncu Yil Univ, Dept Nephrol, Fac Med, Van, Turkey
关键词
Aortic propagation velocity; Arterial stiffness; End-stage renal disease; Pulse wave velocity; Echocardiography; PULSE-WAVE VELOCITY; INTIMA-MEDIA THICKNESS; AORTIC STIFFNESS; ENDOTHELIAL DYSFUNCTION; INDEPENDENT PREDICTOR; KIDNEY-DISEASE; CORONARY; RISK; ATHEROSCLEROSIS; MORTALITY;
D O I
10.1007/s00059-013-3898-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Cardiovascular disease is the leading cause of death among patients with end-stage renal disease (ESRD). Arterial stiffness is an independent predictive parameter of overall and cardiovascular mortality in these patients. However, the defined procedures for the measurement of arterial stiffness are time consuming and not practical in daily practice. Methods. The study population included 50 patients with ESRD who were treated with hemodialysis (HD; n=23) or peritoneal dialysis (PD; n=27) and 70 age-and sex-matched control subjects. Aortofemoral pulse wave velocity (PWV), carotid intima-media thickness (CIMT), and color M-mode propagation velocity of the descending aorta (aortic propagation velocity, APV) were measured. Results. Compared to the control group, the patients with ESRD had significantly lower APV (46.4 +/- 12.4 vs. 58.5 +/- 8.5, p<0.01) and higher PWV (10.5 +/- 2.5 vs. 9.2 +/- 1.2, p<0.01) and CIMT (0.66 +/- 0.15 vs. 0.43 +/- 0.06, p<0.01) measurements. There were significant correlations between APV and CIMT (r=-0.769, p<0.001), APV and PWV (r=-0.682, p<0.001), and PWV and CIMT (r=0.564, p<0.001). There were no significant differences in APV and PWV between the PD and HD patients. Conclusion. Arterial stiffness is an important indicator of atherosclerosis and arterial aging in patients with ESRD. The measurement of APV is an easy and practical new echocardiographic method and may be used to identify arterial stiffness in these patients.
引用
收藏
页码:749 / 754
页数:6
相关论文
共 50 条
  • [41] Can Kidney Transplantation Improve Arterial Stiffness in End-Stage Renal Patients?
    Ro, H.
    Kim, A. J.
    Chang, J. H.
    Jung, J. Y.
    Chung, W. K.
    Park, Y. H.
    Lee, H. H.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (03) : 884 - 886
  • [42] Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease
    Esposito, Pasquale
    Verzola, Daniela
    La Porta, Edoardo
    Milanesi, Samantha
    Grignano, Maria Antonietta
    Avella, Alessandro
    Gregorini, Marilena
    Abelli, Massimo
    Ticozzelli, Elena
    Rampino, Teresa
    Garibotto, Giacomo
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2020, 27 (10) : 1039 - 1052
  • [43] Arterial calcifications and bone histomorphometry in end-stage renal disease
    London, GM
    Marty, C
    Marchais, SJ
    Guerin, AP
    Metivier, F
    De Vernejoul, MC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (07): : 1943 - 1951
  • [44] Arterial stiffening and vascular calcifications in end-stage renal disease
    Guérin, AP
    London, GM
    Marchais, SJ
    Metivier, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (07) : 1014 - 1021
  • [45] The impact of intervention strategies that target arterial stiffness in end-stage renal disease: A systematic review protocol
    Rodriguez R.A.
    Shea B.
    Hae R.
    Burns K.D.
    Systematic Reviews, 5 (1)
  • [46] Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease
    Blacher, J
    Pannier, B
    Guerin, AP
    Marchais, SJ
    Safar, ME
    London, GM
    HYPERTENSION, 1998, 32 (03) : 570 - 574
  • [47] Dietary Fiber Intake: Its Relation With Glycation End Products and Arterial Stiffness in End-Stage Renal Disease Patients
    Demirci, Bahar Gurlek
    Tutal, Emre
    Eminsoy, Irem O.
    Kulah, Eyup
    Sezer, Siren
    JOURNAL OF RENAL NUTRITION, 2019, 29 (02) : 136 - 142
  • [48] End-stage Renal Disease
    Abbasi, Maaz
    Chertow, Glenn
    Hall, Yoshio
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (12) : 1512 - 1514
  • [49] CLINICAL AND ECHOCARDIOGRAPHIC DISEASE IN PATIENTS STARTING END-STAGE RENAL-DISEASE THERAPY
    FOLEY, RN
    PARFREY, PS
    HARNETT, JD
    KENT, GM
    MARTIN, CJ
    MURRAY, DC
    BARRE, PE
    KIDNEY INTERNATIONAL, 1995, 47 (01) : 186 - 192
  • [50] A New Model for the Management of End-Stage Renal Disease
    Al Mosawi, A. J.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1862 - 1862